• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

OxyContin (oxycodone hydrochloride)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011


Summary View



Difficulty Swallowing and Gastrointestinal Effects
  • There have been post-marketing reports of difficulty ...
  • There have been rare post-marketing reports of cases of intestinal obstruction...
  • Use caution when prescribing OxyContin for patients who have difficulty swallowing or have underlying GI disorders that may predispose them to obstruction.
  • The administration of OxyContin may obscure.......